Fluoropolymer-coated dacron versus PTFE grafts for femorofemoral crossover bypass: randomised trial. |
| |
Authors: | J P Eiberg O R?der M Stahl-Madsen N Eldrup P Qvarfordt A Laursen M Greve T Fl?renes O M Nielsen C Seidelin T Vestergaard-Andersen T V Schroeder |
| |
Institution: | Department of Vascular Surgery, Rigshospitalet, Copenhagen, Denmark. jonas@eiberg.org |
| |
Abstract: | OBJECTIVES: To investigate whether patency of a thin walled 8 mm fluoropassivated Dacron graft was similar to that of a standard 8mm PTFE graft for femorofemoral crossover bypass surgery. DESIGN: A randomised multicentre clinical trial comparing two vascular grafts with participation of 10 departments of vascular surgery in Denmark, Sweden and Norway. PATIENTS AND METHODS: 198 patients were randomised to PTFE (n=107) or fluoropolymer-coated Dacron grafts (n=91), 63% underwent surgery for claudication, 27% for ischaemic rest pain and 10% for tissue loss. The median follow-up time was 24 months (IQR 19-26 months). RESULTS: The primary patency rate of the two grafts was similar (log rank test: p=0.35). The primary patency rates (95% CI) for coated Dacron and PTFE grafts were 92% (86-98) and 94% (89-99) at 12 months and 87% (74-95) and 93% (87-99) at 24 months, respectively. CONCLUSION: In patients with unilateral iliac artery disease not amenable to angioplasty, the femoral-femoral bypass is durable and effective. No difference in patency was found between the two graft materials (fluoropolymer coated Dacron and PTFE). |
| |
Keywords: | |
|
|